Literature DB >> 12908937

Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.

Fangbing Liu1, Pablo Lopez Bergami, Mark Duval, David Kuhrt, Marshall Posner, Lisa Cavacini.   

Abstract

Immunoglobulins undergo isotype switching in response to antigenic stimulation. The C(H) domains, in particular the hinge region, impose structural constraints on the interaction of antibody with antigen, especially multivalent antigens such as HIV. We previously showed that switching the IgG1 anti-HIV human monoclonal antibody (HMAb) F105 to an IgG3 resulted in significantly enhanced neutralization of HIV. To further investigate the influence of isotype, including the functional activity of HMAbs switched to IgA, which may be important in mucosal defenses, isotype switched antibodies have been generated for the anti-V3 loop base IgG2 HMAb F425B4e8. Reactivity of the IgG1 antibody was greater than the parental IgG2 antibody for SF2 infected cells but less for primary isolate virions. In contrast, there was less reactivity of the IgG3 with either infected cells or virions. IgA reacted significantly more with infected cells and virions as compared to the IgG subclasses. In contrast to previous studies whereby IgG3 enhanced neutralization, comparable neutralization of primary isolate virus was observed for IgG subclasses (IgG1, IgG2, IgG3) and IgA. This may reflect differences in the exposure of epitopes recognized by the HMAb with antibody flexibility being important to neutralization by antibodies reactive with obscured epitopes (e.g., CD4 binding site). Further analysis of the in vitro activity of isotype or subclass switched antibodies, IgA in particular, alone and in combination with other HMAbs, will provide important information on the role of IgG subclass and IgA antibodies on protective immunity to HIV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12908937     DOI: 10.1089/088922203322230969

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  16 in total

1.  Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody.

Authors:  Daniela Tudor; Huifeng Yu; Julien Maupetit; Anne-Sophie Drillet; Tahar Bouceba; Isabelle Schwartz-Cornil; Lucia Lopalco; Pierre Tuffery; Morgane Bomsel
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-20       Impact factor: 11.205

2.  Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region.

Authors:  Nicholas J Mantis; Jana Palaia; Ann J Hessell; Simren Mehta; Zhiyi Zhu; Blaise Corthésy; Marian R Neutra; Dennis R Burton; Edward N Janoff
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

3.  Sooty mangabey (Cercocebus torquatus atys) IGHG and IGHA genes.

Authors:  Franco Scinicariello; Feda Masseoud; Lakshmi Jayashankar; Roberta Attanasio
Journal:  Immunogenetics       Date:  2006-10-18       Impact factor: 2.846

4.  Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies Are Isotype-Dependent.

Authors:  Blandine Noailly; Melyssa Yaugel-Novoa; Justine Werquin; Fabienne Jospin; Daniel Drocourt; Thomas Bourlet; Nicolas Rochereau; Stéphane Paul
Journal:  Vaccines (Basel)       Date:  2022-06-06

5.  Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1.

Authors:  Miroslaw K Gorny; Xiao-Hong Wang; Constance Williams; Barbara Volsky; Kathy Revesz; Bradley Witover; Sherri Burda; Mateusz Urbanski; Phillipe Nyambi; Chavdar Krachmarov; Abraham Pinter; Susan Zolla-Pazner; Arthur Nadas
Journal:  Mol Immunol       Date:  2008-10-25       Impact factor: 4.407

6.  Dengue virus neutralization is modulated by IgG antibody subclass and Fcgamma receptor subtype.

Authors:  W W Shanaka I Rodrigo; Olivia K T Block; Christopher Lane; Soila Sukupolvi-Petty; Ana P Goncalvez; Syd Johnson; Michael S Diamond; Ching-Juh Lai; Robert C Rose; Xia Jin; Jacob J Schlesinger
Journal:  Virology       Date:  2009-10-14       Impact factor: 3.616

7.  Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates.

Authors:  Christopher Sundling; Mattias N E Forsell; Sijy O'Dell; Yu Feng; Bimal Chakrabarti; Srinivas S Rao; Karin Loré; John R Mascola; Richard T Wyatt; Iyadh Douagi; Gunilla B Karlsson Hedestam
Journal:  J Exp Med       Date:  2010-08-02       Impact factor: 14.307

Review 8.  The structural basis of antibody-antigen recognition.

Authors:  Inbal Sela-Culang; Vered Kunik; Yanay Ofran
Journal:  Front Immunol       Date:  2013-10-08       Impact factor: 7.561

9.  A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: potential impact on CTL epitopes.

Authors:  Alagarsamy Srinivasan; Velpandi Ayyavoo; Sundarasamy Mahalingam; Aarthi Kannan; Anne Boyd; Debduti Datta; Vaniambadi S Kalyanaraman; Anthony Cristillo; Ronald G Collman; Nelly Morellet; Bassel E Sawaya; Ramachandran Murali
Journal:  Virol J       Date:  2008-08-23       Impact factor: 4.099

10.  Isotype switching increases efficacy of antibody protection against staphylococcal enterotoxin B-induced lethal shock and Staphylococcus aureus sepsis in mice.

Authors:  Avanish K Varshney; Xiaobo Wang; Jorge L Aguilar; Matthew D Scharff; Bettina C Fries
Journal:  MBio       Date:  2014-06-10       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.